The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation

被引:105
作者
Tidu, Antonin [1 ]
Janvier, Aurelie [1 ]
Schaeffer, Laure [1 ]
Sosnowski, Piotr [1 ]
Kuhn, Lauriane [2 ]
Hammann, Philippe [2 ]
Westhof, Eric [1 ]
Eriani, Gilbert [1 ]
Martin, Franck [1 ]
机构
[1] Univ Strasbourg, Inst Biol Mol & Cellulaire, Architecture & Reactivite ARN, CNRS UPR9002, F-67084 Strasbourg, France
[2] Univ Strasbourg, CNRS FRC1589, Plateforme Prote Strasbourg Esplanade, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France
关键词
SARS-CoV-2; NSP1; SL1; 5'UTR; translation; ribosome; MESSENGER-RNA; I INTERFERON; GENE-EXPRESSION; INITIATION; PURIFICATION; EVASION; CELLS;
D O I
10.1261/rna.078121.120
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SARS-CoV-2 coronavirus is responsible for the Covid-19 pandemic. In the early phase of infection, the single-strand positive RNA genome is translated into nonstructural proteins (NSP). One of the first proteins produced during viral infection, NSP1, binds to the host ribosome and blocks the mRNA entry channel. This triggers translation inhibition of cellular translation. Despite the presence of NSP1 on the ribosome, viral translation proceeds, however. The molecular mechanism of the so-called viral evasion to NSP1 inhibition remains elusive. Here, we confirm that viral translation is maintained in the presence of NSP1 and we show that the evasion to NSP1-inhibition is mediated by the cis-acting RNA hairpin SL1 in the 5'UTR of SARS-CoV-2. Only the apical part of SL1 is required for viral translation. We further show that NSP1 remains bound on the ribosome during viral translation. We suggest that the interaction between NSP1 and SL1 frees the mRNA accommodation channel while maintaining NSP1 bound to the ribosome. Thus, NSP1 acts as a ribosome gatekeeper, shutting down host translation and fostering SARS-CoV-2 translation in the presence of the SL1 5'UTR hairpin. SL1 is also present and necessary for translation of subgenomic RNAs in the late phase of the infectious program. Consequently, therapeutic strategies targeting SL1 should affect viral translation at early and late stages of infection. Therefore, SL1 might be seen as a genuine "Achilles heel" of the virus.
引用
收藏
页码:253 / 264
页数:12
相关论文
共 50 条
  • [21] Emerging Mutations in Nsp1 of SARS-CoV-2 and Their Effect on the Structural Stability
    Mou, Kejie
    Mukhtar, Farwa
    Khan, Muhammad Tahir
    Darwish, Doaa B.
    Peng, Shaoliang
    Muhammad, Shabbir
    Al-Sehemi, Abdullah G.
    Wei, Dong-Qing
    PATHOGENS, 2021, 10 (10):
  • [22] Cap-independent translation and a precisely located RNA sequence enable SARS-CoV-2 to control host translation and escape anti-viral response
    Slobodin, Boris
    Sehrawat, Urmila
    Lev, Anastasia
    Hayat, Daniel
    Zuckerman, Binyamin
    Fraticelli, Davide
    Ogran, Ariel
    Ben-Shmuel, Amir
    Bar-David, Elad
    Levy, Haim
    Ulitsky, Igor
    Dikstein, Rivka
    NUCLEIC ACIDS RESEARCH, 2022, 50 (14) : 8080 - 8092
  • [23] SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses
    Banerjee, Abhik K.
    Blanco, Mario R.
    Bruce, Emily A.
    Honson, Drew D.
    Chen, Linlin M.
    Chow, Amy
    Bhat, Prashant
    Ollikainen, Noah
    Quinodoz, Sofia A.
    Loney, Colin
    Thai, Jasmine
    Miller, Zachary D.
    Lin, Aaron E.
    Schmidt, Madaline M.
    Stewart, Douglas G.
    Goldfarb, Daniel
    De Lorenzo, Giuditta
    Rihn, Suzannah J.
    Voorhees, Rebecca M.
    Botten, Jason W.
    Majumdar, Devdoot
    Guttman, Mitchell
    CELL, 2020, 183 (05) : 1325 - +
  • [24] SARS-CoV-2 Nsp1 traps RNA in the nucleus to escape immune detection
    Guillen, Jaresley V.
    Glaunsinger, Britt A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (25)
  • [25] SARS-CoV-2 competes with host mRNAs for efficient translation by maintaining the mutations favorable for translation initiation
    Zhang, Yanping
    Jin, Xiaojie
    Wang, Haiyan
    Miao, Yaoyao
    Yang, Xiaoping
    Jiang, Wenqing
    Yin, Bin
    JOURNAL OF APPLIED GENETICS, 2022, 63 (01) : 159 - 167
  • [26] SARS-CoV-2 competes with host mRNAs for efficient translation by maintaining the mutations favorable for translation initiation
    Yanping Zhang
    Xiaojie Jin
    Haiyan Wang
    Yaoyao Miao
    Xiaoping Yang
    Wenqing Jiang
    Bin Yin
    Journal of Applied Genetics, 2022, 63 : 159 - 167
  • [27] Prevention of ribosome collision-induced neuromuscular degeneration by SARS CoV-2-encoded Nsp1
    Wang, Xingjun
    Rimal, Suman
    Tantray, Ishaq
    Geng, Ji
    Bhurtel, Sunil
    Khaket, Tejinder Pal
    Li, Wen
    Han, Zhe
    Lu, Bingwei
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (42)
  • [28] SARS-CoV-2 nsp1: Bioinformatics, Potential Structural and Functional Features, and Implications for Drug/Vaccine Designs
    Min, Yuan-Qin
    Mo, Qiong
    Wang, Jun
    Deng, Fei
    Wang, Hualin
    Ning, Yun-Jia
    FRONTIERS IN MICROBIOLOGY, 2020, 11
  • [29] Quinoin, type 1 ribosome inactivating protein alters SARS-CoV-2 viral replication organelle restricting viral replication and spread
    Tiano, Sofia Maria Luigia
    Landi, Nicola
    Marano, Valentina
    Ragucci, Sara
    Bianco, Gennaro
    Cacchiarelli, Davide
    Swuec, Paolo
    Silva, Malan
    De Cegli, Rossella
    Sacco, Francesca
    Di Maro, Antimo
    Cortese, Mirko
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 280
  • [30] Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA
    Yuan, Shuai
    Peng, Lei
    Park, Jonathan J.
    Hu, Yingxia
    Devarkar, Swapnil C.
    Dong, Matthew B.
    Shen, Qi
    Wu, Shenping
    Chen, Sidi
    Lomakin, Ivan B.
    Xiong, Yong
    MOLECULAR CELL, 2020, 80 (06) : 1055 - +